Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2HUUSKO, P; CASTREN, K; LAUNONEN, V et al.Cancer genetics and cytogenetics. 1999, Vol 112, Num 1, pp 9-14, issn 0165-4608Conference Paper

ATM mutations in finnish breast cancer patientsALLINEN, M; LAUNONEN, V; LAAKE, K et al.Journal of medical genetics. 2002, Vol 39, Num 3, pp 192-196, issn 0022-2593Article

Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families : a novel mutation BRCA2 3414de14 found in male breast cancerBALCI, A; HUUSKO, P; PÄÄKKÖNEN, K et al.European journal of cancer (1990). 1999, Vol 35, Num 5, pp 707-710, issn 0959-8049Article

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sitesRAPAKKO, K; ALLINEN, M; WINQVIST, R et al.British journal of cancer. 2001, Vol 84, Num 1, pp 116-119, issn 0007-0920Article

Mutation analysis of the CHK2 gene in families with hereditary breast cancerALLINEN, M; HUUSKO, P; MÄNTYNIEMI, S et al.British journal of cancer. 2001, Vol 85, Num 2, pp 209-212, issn 0007-0920Article

European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients : relation to clinical variablesLAUNONEN, V; LAAKE, K; SEITZ, S et al.British journal of cancer. 1999, Vol 80, Num 5-6, pp 879-882, issn 0007-0920Article